Pescaru Camelia Corina, Crisan Alexandru Florian, Marc Monica, Trusculescu Ana Adriana, Maritescu Adelina, Pescaru Andrei, Sumenkova Anastasiia, Bratosin Felix, Oancea Cristian, Vastag Emanuela
Center for Research and Innovation in Personalized Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Pulmonology Clinic, Clinical Hospital of Infectious Diseases and Pulmonology, "Victor Babes", Gheorghe Adam Street 13, 300310 Timisoara, Romania.
J Clin Med. 2023 Jul 24;12(14):4854. doi: 10.3390/jcm12144854.
The acute phase of COVID-19 often leaves patients with persistent pulmonary deficits. Pulmonary Rehabilitation (PR) has been recommended as an essential part of post-acute COVID-19 management. In light of the global pandemic, telerehabilitation has been increasingly employed to deliver PR. This systematic review aimed to evaluate the effectiveness of telemedicine-driven PR in patients recovering from the acute phase of COVID-19, assessing variations in telerehabilitation practices and identifying the degree of change in mental health, physical health, quality of life, and lung function. A systematic search was conducted across PubMed, Web of Science, Cochrane, and Scopus up until April 2023. Studies focusing on telerehabilitation in PR for post-acute COVID-19 patients with outcomes including pulmonary function, exercise capacity, and quality of life were included after careful assessment of this study's protocol. The selection process involved careful scrutiny of abstracts and full texts, and the quality assessment was performed using the National Heart, Lung, and Blood Institute (NHLBI) tool. Seven studies, published between 2021 and 2022, involving a total of 412 patients, were included. The evaluated telerehabilitation programs stretched between 4 and 10 weeks, involving a mobile app or video connection with the patient, integrating a mix of aerobic and resistance training, breathing exercises, functional activities, and muscle strengthening. Findings revealed that telemedicine-driven PR significantly improved physical health, measured by the step test score (73 vs. 71), 6MWD (30.2 vs. 17.1) and BPAQ, mental health evaluated by SF-12 (6.15 vs. 4.17) and PHQ-4, quality of life measured by the SF-12 (7.81 vs. 3.84), SGRQ (31.5 vs. 16.9), and CAT scores, and some parameters of pulmonary function in post-acute COVID-19 patients (mMRC, STST, and MVV). This review substantiates the potential of telemedicine-driven PR to improve various health outcomes in post-acute COVID-19 patients. The findings underscore the importance of integrating telerehabilitation into the management of post-acute COVID-19 and call for further exploration of its long-term effects, cost-effectiveness, and best practices.
新冠病毒病(COVID-19)急性期常使患者遗留持续性肺部功能缺陷。肺康复(PR)已被推荐为COVID-19急性期后管理的重要组成部分。鉴于全球大流行,远程康复越来越多地用于提供肺康复服务。本系统评价旨在评估远程医疗驱动的肺康复对COVID-19急性期康复患者的有效性,评估远程康复实践的差异,并确定心理健康、身体健康、生活质量和肺功能的变化程度。截至2023年4月,在PubMed、科学网、考科蓝和Scopus数据库中进行了系统检索。在仔细评估本研究方案后,纳入了针对COVID-19急性期后患者进行肺康复远程康复且结果包括肺功能、运动能力和生活质量的研究。选择过程包括对摘要和全文的仔细审查,并使用美国国立心肺血液研究所(NHLBI)工具进行质量评估。纳入了2021年至2022年发表的7项研究,共涉及412例患者。评估的远程康复计划为期4至10周,包括使用移动应用程序或与患者进行视频连接,综合有氧运动和抗阻训练、呼吸练习、功能活动和肌肉强化。研究结果显示,远程医疗驱动的肺康复显著改善了身体健康,以阶梯试验评分(73对71)、6分钟步行距离(30.2对17.1)和BPAQ衡量;改善了心理健康,以SF-12(6.15对4.17)和PHQ-4评估;改善了生活质量,以SF-12(7.81对3.84)、SGRQ(31.5对16.9)和CAT评分衡量;还改善了COVID-19急性期后患者的一些肺功能参数(mMRC、STST和MVV)。本评价证实了远程医疗驱动的肺康复改善COVID-19急性期后患者各种健康结局的潜力。研究结果强调了将远程康复纳入COVID-19急性期后管理的重要性,并呼吁进一步探索其长期效果、成本效益和最佳实践。